Axiom Investors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-59,677
| Closed | -$32.2M | – | 136 |
|
|
2024
Q1 | $32.2M | Buy |
59,677
+798
| +1% | +$431K | 0.28% | 47 |
|
|
2023
Q4 | $32.7M | Sell |
58,879
-71,054
| -55% | -$39.4M | 0.32% | 48 |
|
|
2023
Q3 | $56.8M | Sell |
129,933
-129,418
| -50% | -$56.6M | 0.82% | 34 |
|
|
2023
Q2 | $130M | Buy |
259,351
+4,750
| +2% | +$2.39M | 1.94% | 17 |
|
|
2023
Q1 | $127M | Buy |
254,601
+86,795
| +52% | +$43.4M | 2.1% | 17 |
|
|
2022
Q4 | $68.5M | Buy |
167,806
+37,890
| +29% | +$15.5M | 1.35% | 24 |
|
|
2022
Q3 | $42.3M | Buy |
129,916
+28,152
| +28% | +$9.17M | 0.89% | 34 |
|
|
2022
Q2 | $35.7M | Buy |
101,764
+447
| +0.4% | +$157K | 1.07% | 28 |
|
|
2022
Q1 | $55.4M | Sell |
101,317
-56,070
| -36% | -$30.7M | 1.31% | 25 |
|
|
2021
Q4 | $104M | Buy |
157,387
+7,322
| +5% | +$4.82M | 1.91% | 16 |
|
|
2021
Q3 | $93.3M | Sell |
150,065
-62,294
| -29% | -$38.7M | 1.54% | 23 |
|
|
2021
Q2 | $134M | Buy |
212,359
+41,927
| +25% | +$26.5M | 2.16% | 12 |
|
|
2021
Q1 | $83.4M | Buy |
170,432
+4,026
| +2% | +$1.97M | 1.51% | 19 |
|
|
2020
Q4 | $83.2M | Sell |
166,406
-480
| -0.3% | -$240K | 1.31% | 25 |
|
|
2020
Q3 | $65.6M | Buy |
166,886
+49,683
| +42% | +$19.5M | 1.06% | 25 |
|
|
2020
Q2 | $38.7M | Buy |
117,203
+9,849
| +9% | +$3.25M | 0.76% | 35 |
|
|
2020
Q1 | $26M | Buy |
107,354
+7,923
| +8% | +$1.92M | 0.66% | 37 |
|
|
2019
Q4 | $26M | Buy |
99,431
+4,880
| +5% | +$1.27M | 0.6% | 48 |
|
|
2019
Q3 | $25.7M | Sell |
94,551
-37,715
| -29% | -$10.3M | 0.69% | 44 |
|
|
2019
Q2 | $36.4M | Buy |
132,266
+40,823
| +45% | +$11.2M | 1% | 30 |
|
|
2019
Q1 | $20.4M | Buy |
+91,443
| New | +$20.4M | 0.63% | 39 |
|